cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Amphastar Pharmaceuticals Inc
10 own
26 watching
Current Price
$45.96
$0.45
(0.99%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,895.65M
52-Week High
52-Week High
67.66000
52-Week Low
52-Week Low
26.76000
Average Volume
Average Volume
0.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
95.1793
iconMarket Capitalization2,895.65M
icon52-Week High67.66000
icon52-Week Low26.76000
iconAverage Volume0.11M
iconDividend Yield--
iconP/E Ratio95.1793
What does the Amphastar Pharmaceuticals Inc do?
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable, inhalation, and intranasal products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company's product portfolio comprises enoxaparin, a low molecular weight heparin that is used as an anticoagulant for prevention and treatment of deep vein thrombosis; naloxone for treating opioid overdose; Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection for the dispersion and absorption of other injected drugs; and lidocaine jelly, a local anesthetic product for urological procedures. It also provides lidocaine topical solution for various procedures; phytonadione injection for newborn babies; syringe products, which include critical care drugs, such as morphine, atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; lorazepam injection for surgery and medical procedures; ketorolac for acute pain management; and procainamide for documented ventricular arrhythmias. In addition, the company manufactures and distributes recombinant human insulin and porcine insulin. Further, it develops Primatene Mist, an over-the-counter epinephrine inhalation product candidate that is intended to be used for the temporary relief of mild symptoms of intermittent asthma. Additionally, the company has a pipeline of 20 generic and proprietary product candidates in various stages of development for various indications. Its products are used in hospital or urgent care clinical settings, and primarily contracted and distributed through group purchasing organizations and drug wholesalers. The company was established in 1996 and is headquartered in Rancho Cucamonga, California.
Read More
How much money does Amphastar Pharmaceuticals Inc make?
News & Events about Amphastar Pharmaceuticals Inc.
Ticker Report
3 months ago
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH Get Rating) EVP Rong Zhou sold 5,000 shares of the companys stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $51.79, for a total value of $258,950.00. Following the transaction, the ...
Zolmax
3 months ago
Amphastar Pharmaceuticals (NASDAQ:AMPH Get Rating) and Crinetics Pharmaceuticals (NASDAQ:CRNX Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, ...
Ticker Report
4 months ago
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH Get Rating) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,440,000 shares, an increase of 9.9% from the March 31st total of 1,310,000 shares. Approximately 4...
Accesswire
5 months ago
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 24, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will provide a Business update and hold a Conference call today, Monday, April 24, 2023, at 6:00 am Pacific Time.To access the conference call, please dial 877-407-0989, or...
Zolmax
6 months ago
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH Get Rating) from a buy rating to a strong-buy rating in a research report report published on Tuesday . Amphastar Pharmaceuticals Stock Down 0.2 % AMPH stock opened at $35.36 on Tuesday. The firm has a 50-day moving average ...
Frequently Asked Questions
Frequently Asked Questions
What is Amphastar Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Amphastar Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Amphastar Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Amphastar Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Amphastar Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Amphastar Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Amphastar Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Amphastar Pharmaceuticals Inc?
plus_minus_icon
What percentage is Amphastar Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Amphastar Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$45.96
$0.45
(0.99%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Revance Therapeutics Inc
Revance Therapeutics Inc
$12.57
$-0.44 (-3.38 %)
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc.
$41.30
$0.30 (0.73 %)
Blueprint Medicines Corp
Blueprint Medicines Corp
$49.40
$-0.12 (-0.24 %)
Galapagos NV
Galapagos NV
$34.70
$-0.55 (-1.56 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Revance Therapeutics Inc
Revance Therapeutics Inc
$12.57
$-0.44 (-3.38 %)
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc.
$41.30
$0.30 (0.73 %)
Blueprint Medicines Corp
Blueprint Medicines Corp
$49.40
$-0.12 (-0.24 %)
Galapagos NV
Galapagos NV
$34.70
$-0.55 (-1.56 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00